Key selective action features: No Growth Hormone Receptor Binding: Does not activate GH receptors responsible for IGF-1 stimulation and systemic growth effects Preserved Glucose Metabolism: No impact on blood sugar regulation, insulin sensitivity, or diabetic risk markers No Tissue Growth Effects: Does not promote muscle hypertrophy, organ growth, or cell proliferation pathways Adipose-Specific Targeting: Works primarily through beta-3 adrenergic receptors concentrated in fat tissue No IGF-1 Elevation: Clinical trials confirmed no changes in serum IGF-1 levels at therapeutic doses Isolated Lipolytic Action: Maintains the fat-breaking properties of growth hormone fragment 176-191 without broader effects Selective Mechanism: Structural differences from full-length GH prevent binding to receptors mediating non-fat-related effects Clinical Validation: Human studies in 900+ participants confirmed selective fat metabolism without systemic hormonal changes The following guide provides detailed analysis of AOD-9604 s selective action and why this selectivity matters for safe, targeted fat metabolism
Mitsui, T
Symptoms include high-pitched cries, tremors and gastrointestinal problems
Here is the full breakdown by category, with pricing as stated by the company: Injectable Therapies According to company materials, AgelessRx offers eight injectable treatments focused on cellular metabolism, growth hormone support, and antioxidant pathways: NAD+ Injection (starting at $235/month as of March 2026 per company materials): Presented by the company within discussions of cellular metabolism and age-related NAD+ decline
Content presented on the website does not constitute medical advice, nor should it be relied upon to medically prescribe or diagnose any illness or disease for which the treatment is available in the customers country
Oxidative stress assumes a critical role in AD and other dermatological conditions, evidenced by increased oxidative stress marker levels and diminished antioxidant levels in affected individuals (38)
